News
August 22, 2019
Reveles Clinical Services is working to make clinical trials more accessible to the patients that need them. Scheduled to hit the market next spring, Reveles will […]
June 10, 2019
The 2019 Rare Drug Development Symposium, held in Philadelphia June 6th and 7th, was hosted by Global Genes and the Orphan Disease Center at the University […]
May 29, 2019
New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO. Ahead of 2019’s annual American […]
May 4, 2019
Interested in conducting market research at an upcoming medical conference? The MedPanel team is experienced in gathering feedback from attendees before, during and after conferences. The […]
April 29, 2019
100 rare disease treaters in the US and the UK shared their biggest challenges in treating and managing rare disease patients. MedPanel conducted research with physicians […]
March 25, 2019
MedPanel asked 100 rare disease treaters in the US and the UK if pharmaceutical companies should be involved in rare disease patient advocacy groups. A little […]
March 19, 2019
Prapela has been awarded the first SBIR grant by The National Institute on Drug Abuse (NIDA). Prapela will use the grant to advance the development of […]
February 28, 2019
In what care setting do doctors see patients with rare diseases? How do they keep up with treatment advances? Can pharmaceutical companies support rare disease treaters […]
February 21, 2019
Offering Our Clients Consulting, Research and Patient Recruitment CAMBRIDGE, MA – 02/21/2019 (PRDistribution.com) MedPanel, Inc., today announced the launch of a new division, rarediseasematters.com, which will provide […]